Jinan Chuan Cheng Pharmaceutical R&D Co., Ltd.

Company Description

Jinan Chuan Cheng Pharmaceutical R&D Co., Ltd. (CCPH for short) founded in 2003. CCPH is a High-Tech enterprise which is dedicated to R&D APIs, Intermediates and Pharmaceutical preparations.

CCPH takes management strictly according to GMP and ISO Standard, and independently develops industrialization production main products including Clemastine Fumarate, Phosphonoformic acid trisodium salt hexahydrate, Setastine hydrochloride, Carteolol Hydrochloride, Olsalazine Sodium, Trimethylsulfoxonium Bromide, etc. The company is the most competitive production enterprise in China and has passed quality audit from foreign famous pharmaceutical enterprises.

CCPH owns trade import and export authority. Jinan Chuan Cheng Pharmaceutical R&D Co., Ltd. products take international market as priority and domestic market as supplement, and are mainly exported to Europe, America, India, Japan, Korea and other areas. Strict product quality, reasonable price and considerate sales service can gain recognition from the customers.

CCPH always insists on quality management guideline of technology leading, quality rigidity, customer satisfaction and sustainable improvement and EHS guideline of saving energy, protecting environment, safety first and protecting health to develop strongly.

CCPH another new modern plant is under building, the new plant covers an area of 60,000 more square meters, and it will be built according to GMP Standard strictly.

Company Information

  • Contact Person:Mr. Libor
  • Job Title:Sales Manager, Sales
  • Telephone:
  • Fax:
  • Zip:250101
  • Business Type:Manufacturer,Exporter
  • Number Of Employees:100 to 249
  • Main Products:Clemastine Fumarate, Olsalazine Sodium, Trimethylsulfoxonium Bromide,
  • Address:No. 15, North of Lieshishan Road
  • Main Markets:World Wide
  • Location:Jinan, Shandong,China
  • Website:Visit website

Product

  • Clemastine Fumarate (CAS No. 14976-57-9)
  • Phosphonoformic acid trisodium salt hexahydrate (CAS 34156-56-4)
  • Setastine hydrochloride (CAS 59767-13-4)
  • Carteolol Hydrochloride (CAS 51781-21-6)
  • Olsalazine Sodium (CAS No. 6054-98-4)
  • Bepotastine besilate (CAS 190786-44-8)
  • Bosentan (CAS 147536-97-8)
  • Agomelatine (CAS 138112-76-2)
  • Imidocarb Dipropionate (CAS 55750-06-6)
  • Flunixin meglumin (CAS 42461-84-7)
  • Sertaconazole nitrate (CAS 99592-39-9)
  • Benactyzine hydrochloride (CAS 57-37-4)
  • Clopidogrel sulfate (CAS 135046-48-9)
  • 1-Methyl-2-pyrrolidineethanol (CAS 67004-64-2)
  • Trimethylsulfoxonium Bromide (CAS 25596-24-1)
  • Trimethylsulfoxonium iodide (CAS 1774-47-6)
  • 5-Aminolevulinic acid hydrochloride (CAS No. 5451-09-2)
  • 1-Methyl-2-(2-aminoethyl)pyrrolidine (CAS 51387-90-7)
  • 1-(2-Chloroethyl)azepane hydrochloride (CAS 26487-67-2)
  • 2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine (CAS 122368-54-1)
  • Trimethylsulfoxonium chloride (CAS 5034-06-0)
  • Milrinone (CAS 78415-72-2)
  • Methylbenactyzium bromide (CAS 3166-62-9)
  • Nafcillin sodium salt monohydrate (CAS 7177-50-6)
  • Esomeprazole (CAS 119141-88-7)
  • 1-(1-(4-chlorophenyl)vinyl)benzene (CAS 18218-20-7)
  • 1-(4-Chlorophenyl)-1-phenylethanol (CAS 59767-24-7)
  • 5-Hydroxy-3,4-Dihydro-1H-Quinolin-2-One (CAS 30389-33-4)
  • N-(2-Hydroxyethyl)Hexamethyleneimine (CAS 20603-00-3)
  • 1,3,4,6-Tetra-O-acetyl-2-O-trifluoromethanesulfonyl-beta-D-mannopyranose (CAS 92051-23-5)
  • Clopidogrel Related Compound A (CAS 144750-42-5)
  • Clopidogrel Related Compound B (CAS No. 144750-52-7)
  • Clopidogrel Related Compound C (CAS 120202-71-3)
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries